Ophthalmic Diagnosis and Novel Management of Infantile Refsum Disease with Combination Docosahexaenoic Acid and Cholic Acid [PDF]
Case Reports in Ophthalmological Medicine, 2021 Infantile Refsum disease is a rare peroxisomal biogenesis disorder characterized by impaired alpha-oxidation and accumulation of phytanic acid in the tissues. Patients often present with fundus changes resembling retinitis pigmentosa, developmental delay,
Omar Elghawy +4 more
doaj +2 more sources
Improved electroretinographic responses following dietary intervention in a patient with Refsum disease [PDF]
JIMD Reports, 2020 Refsum disease is a rare inherited metabolic disorder arising from a defect in peroxisomal metabolism. Patients lack the functional enzyme phytanoyl‐CoA hydroxylase, resulting in perturbed alpha oxidation of fatty acids.
Matthew D. Benson +3 more
doaj +2 more sources
PEX6 Mutation in a Child with Infantile Refsum Disease—A Case Report and Literature Review [PDF]
Children, 2023 The aim of this paper is to describe the temporal progression and clinical picture of a 2-year-old child with infantile Refsum disease, as well as the diagnostic procedures performed; this case presented multiple hematologic, metabolic, and developmental
Ana-Maria Slanina +9 more
doaj +2 more sources
Dilated cardiomyopathy revealing Refsum disease: a case report [PDF]
Journal of Medical Case ReportsBackground Refsum disease is a rare autosomal recessive hereditary disorder of lipid metabolism that results in the accumulation of phytanic acid. This syndrome is characterized with a range of classic symptoms including ataxia, peripheral neuropathy ...
Salim Arous +5 more
doaj +2 more sources
A unique case of microspherophakia in adult Refsum disease [PDF]
American Journal of Ophthalmology Case ReportsAdult Refsum disease (RD) is a rare autosomal recessive peroxisomal disorder with an estimated prevalence of fewer than 1 in 1 million. The ocular manifestations result from the accumulation of phytanic acid, leading to retinitis pigmentosa, attenuated ...
Catherine Liu +3 more
doaj +2 more sources
Midlife diagnosis of Refsum Disease in siblings with Retinitis Pigmentosa – the footprint is the clue: a case report [PDF]
Journal of Medical Case Reports, 2008 Introduction Refsum disease is a potentially lethal and disabling condition associated with retinitis pigmentosa in which early treatment can prevent some of the systemic manifestations.
Jayaram Hari, Downes Susan M
doaj +2 more sources
Pediatric Neurology Briefs, 1988 Two patients with infantile Refsum (phytanic acid storage) disease were treated at 9 mos and 5½ years of age with a low phytanic acid diet and the effects studied over a 2-yr period or longer in the Depts of Chemical Pathology, Neurology and ...
J Gordon Millichap
doaj +3 more sources
Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. [PDF]
, 2000 Leukodystrophies (LD) and genetic leukoencephalopathies (gLE) are disorders that result in white matter abnormalities in the central nervous system (CNS).
Bouter, L.M. +7 more
core +18 more sources
QJM, 2001 Refsum's disease (hereditary motor and sensory neuropathy type IV) is a rare autosomal recessive condition first characterized by Sigvald Refsum in 1945. He initially chose the name heredoataxia hemeralopica polyneuritiformis,1 subsequently amending this to heredopathia atactica polyneuritiformis.2 Thankfully, the eponymous version now predominates in ...
A J, Wills, N J, Manning, M M, Reilly
openaire +2 more sources
Folate catabolites in spot urine as non-invasive biomarkers of folate status during habitual intake and folic acid supplementation. [PDF]
, 2013 Folate status, as reflected by red blood cell (RCF) and plasma folates (PF), is related to health and disease risk. Folate degradation products para-aminobenzoylglutamate (pABG) and para-acetamidobenzoylglutamate (apABG) in 24 hour urine have recently ...
A Lobo +61 more
core +9 more sources